Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temsirolimus vs Interferon Alfa in Advanced Renal Cell Carcinoma
NCT00065468Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jul 2003
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 25
01
Overview
A Phase 3 trial of temsirolimus in renal cell carcinoma (RCC), sponsored by Pfizer. Started Jul 2003; status: completed.
02
Drugs
temsirolimus
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00065468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00065468.